A CGM study shows benefits for non-insulin users with Type 2 diabetes, lowering blood sugar levels over 26 weeks.

Orthofix pays executives approximately $24 million in damages related to breach of contract claims, one of the largest executive payouts.

Johnson & Johnson’s medtech revenue growth stalls at 2.5% in Q3, missing projections amid Abiomed’s underperformance after a $16.6B acquisition.

Ascensia Diabetes Care led a $36 million Series B round for glucose sensor maker Sava Technologies, following an exclusive commercialization agreement in Europe

Upcoming medtech conferences in San Francisco, Las Vegas, and Rome, covering topics like artificial intelligence and cardiac care at medtech events.

Medtech lobby seeks broader device eligibility for Medicare coverage of breakthrough devices with FDA authorization.

Healthcare sector may lag in quantum security, compromising patient information encryption mechanisms.

Zenflow secures $52 million in funding for its urology device to treat benign prostatic hyperplasia.

UK regulator backs ongoing oversight of AI-powered medical tools, emphasizing need for ongoing ai device oversight period.

Stryker CEO Kevin Lobo steps down after 15 years, with COO Spencer Stiles taking over as CEO from January 1.